VentriNova is Drug Discovery in United States that focus on gene therapy business. Founded in 2006. They cover business area such as developer, regenerative medicine, clinical treatment, gene therapy, heart tissue, cardiac damage, activation, intrinsic repair pathway, de novo heart muscle cell, healthcare provider, patient, heart failure.
2006
( 18 years old in 2024 )
Gene Therapy
-
1 Columbus Place
Apartment S22G
New York, NY 10019
United States
Private
developerregenerative medicineclinical treatmentgene therapyheart tissuecardiac damageactivationintrinsic repair pathwayde novo heart muscle cellhealthcare providerpatientheart failure
* We use standard office opening hours in near VentriNova's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
VentriNova is Drug Discovery business from United States that founded in 2006 (18 years old in 2024), VentriNova business is focusing on Gene Therapy.
VentriNova headquarter office and corporate office address is located in 1 Columbus Place Apartment S22G New York, NY 10019 United States.
VentriNova was founded in United States.
In 2024, VentriNova is currently focus on gene therapy sector.
Above is snippet of Google Trends for "gene therapy" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with VentriNova, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
